SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VICL (Vical Labs)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1972 55 0 VICL
Emcee:  bob clark Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1697Vaxgen, Hollis-Eden get BioShield boost By Val Brickates Kennedy, CBS.MarketWabob zagorin-11/5/2004
1696Vical Updates Data From Allovectin-7(R) Phase 2 Melanoma Trial Friday November 5bob zagorin-11/5/2004
1695Tuesday, November 2, 2004 Anthrax vaccine to be studied in Seattle Military seebob zagorin-11/3/2004
1694Vical Announces Third-Quarter 2004 Financial Results Tuesday November 2, 8:31 ambob zagorin-11/2/2004
1693October 29, 2004 Vaccines Are Good Business for Drug Makers (Vical in story) By bob zagorin-10/29/2004
1692Panel Reviews New Vaccine That Could Be Controversial By GARDINER HARRIS Publisbob zagorin-10/27/2004
1691Vical Announces News Release and Conference Call Schedule for Third Quarter 2004bob zagorin-10/26/2004
1690Genetronics and Vical Establish Worldwide License for MedPulser(R) DNA Delivery bob zagorin-10/26/2004
1689U.S. Bioterror Plan Frustrates Industry By PAUL ELIAS The Associated Press SAbob zagorin-10/17/2004
1688October 15, 2004 Malaria Vaccine Proves Effective By DONALD G. McNEIL Jr. For tbob zagorin-10/15/2004
1687Growing Threat As Virus Spreads, Views of West Nile Grow Even Darker Quest fobob zagorin-10/14/2004
1686Vical Appoints Church as Chief Financial Officer Monday October 11, 4:05 pm ET bob zagorin-10/12/2004
1685US drug industry seeks more anti-terror incentives By Susan Heavey WASHINGTON,bob zagorin-10/8/2004
1684i know vical has a state of the art vaccine mfg center but i don't know whetbob zagorin-10/7/2004
1683Vical Initiates Phase 1 Clinical Trial With Trivalent CMV Vaccine Wednesday Septbob zagorin-9/29/2004
1682Gene clue to malaria drug failure Resistance to malaria drugs can make treatmebob zagorin-9/27/2004
1681Vical Inc. (VICL) Announces European Patent Developments SAN DIEGO, Sept. 23 /bob zagorin-9/23/2004
1680Vical Announces Publication of Anthrax Vaccine Protection Data SAN DIEGO, Sept.bob zagorin-9/15/2004
1679thanks. i actually understood much of that ;)bob zagorin-9/1/2004
1678[A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-medituck-9/1/2004
1677Scientists Discover New Approaches to Manipulating AIDS Virus Researchers at thbob zagorin-8/17/2004
1676Clue to stopping killer viruses Retroviruses insert their genetic material intbob zagorin-8/16/2004
1675new 10Q excerpts biz.yahoo.combob zagorin-8/9/2004
1674Vical Announces Second-Quarter 2004 Financial Results Tuesday August 3, 8:31 am bob zagorin-8/4/2004
1673Vical Announces European Patent for Vaxfectin(TM) Adjuvant Wednesday August 4, 8bob zagorin-8/4/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News